285 related articles for article (PubMed ID: 20715911)
1. Cost-effectiveness of strontium ranelate for the prevention and treatment of osteoporosis.
Hiligsmann M; Vanoverberghe M; Neuprez A; Bruyère O; Reginster JY
Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):359-66. PubMed ID: 20715911
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of strontium ranelate versus risedronate in the treatment of postmenopausal osteoporotic women aged over 75 years.
Hiligsmann M; Bruyère O; Reginster JY
Bone; 2010 Feb; 46(2):440-6. PubMed ID: 19716940
[TBL] [Abstract][Full Text] [Related]
3. Strontium ranelate: a look back at its use for osteoporosis.
Reginster JY; Neuprez A
Expert Opin Pharmacother; 2010 Dec; 11(17):2915-27. PubMed ID: 21050035
[TBL] [Abstract][Full Text] [Related]
4. [The necessity of cost-effectiveness analysis in osteoporosis].
Lamy O; Krieg MA
Rev Med Suisse; 2007 Jun; 3(115):1521-5. PubMed ID: 17682796
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of pharmacological agents in managing osteoporosis in the old old: review of the evidence.
Inderjeeth CA; Foo AC; Lai MM; Glendenning P
Bone; 2009 May; 44(5):744-51. PubMed ID: 19130909
[TBL] [Abstract][Full Text] [Related]
6. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
[TBL] [Abstract][Full Text] [Related]
7. An economic evaluation of strontium ranelate in the treatment of osteoporosis in a Swedish setting: based on the results of the SOTI and TROPOS trials.
Borgström F; Jönsson B; Ström O; Kanis JA
Osteoporos Int; 2006 Dec; 17(12):1781-93. PubMed ID: 17009083
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of strontium ranelate for the prevention of osteoporotic fragility fractures in postmenopausal women.
Stevenson M; Davis S; Lloyd-Jones M; Beverley C
Health Technol Assess; 2007 Feb; 11(4):1-134. PubMed ID: 17280622
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate for osteoporosis?
Drug Ther Bull; 2006 Apr; 44(4):29-32. PubMed ID: 16617933
[TBL] [Abstract][Full Text] [Related]
10. Strontium ranelate: vertebral and non-vertebral fracture risk reduction.
Seeman E
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S17-20. PubMed ID: 16735841
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis.
Borgström F; Ström O; Coelho J; Johansson H; Oden A; McCloskey E; Kanis JA
Osteoporos Int; 2010 Feb; 21(2):339-49. PubMed ID: 19513577
[TBL] [Abstract][Full Text] [Related]
12. [How to prevent early postmenopausal fracture risk? Proposition of a strategy].
Trémollieres F; Pouilles JM; Ribot C
Gynecol Obstet Fertil; 2009 Jan; 37(1):50-6. PubMed ID: 19110461
[TBL] [Abstract][Full Text] [Related]
13. Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age.
Seeman E; Boonen S; Borgström F; Vellas B; Aquino JP; Semler J; Benhamou CL; Kaufman JM; Reginster JY
Bone; 2010 Apr; 46(4):1038-42. PubMed ID: 20026265
[TBL] [Abstract][Full Text] [Related]
14. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis.
Neuprez A; Hiligsmann M; Scholtissen S; Bruyere O; Reginster JY
Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755
[TBL] [Abstract][Full Text] [Related]
15. Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review.
Boonen S
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S21-7. PubMed ID: 16735842
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women.
Hiligsmann M; Bruyère O; Reginster JY
Osteoporos Int; 2010 Jan; 21(1):157-65. PubMed ID: 19350339
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis: from early fracture prevention to better bone health with strontium ranelate.
Cortet B
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv14-9. PubMed ID: 19783589
[TBL] [Abstract][Full Text] [Related]
18. Strontium ranelate in the prevention of osteoporotic fractures.
Reginster JY; Malaise O; Neuprez A; Bruyere O
Int J Clin Pract; 2007 Feb; 61(2):324-8. PubMed ID: 17263720
[TBL] [Abstract][Full Text] [Related]
19. Strontium ranelate: new perspectives for the management of osteoporosis.
Cortet B
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv1-2. PubMed ID: 19783588
[No Abstract] [Full Text] [Related]
20. Continuous broad protection against osteoporotic fractures with strontium ranelate.
Ferrari S
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv20-4. PubMed ID: 19783590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
